Use of Affimer Technology for Inhibition of α2-antiplasmin and Enhancement of Fibrinolysis.
Pechlivani N, Alsayejh B, Almutairi MK, Simmons K, Gaule T, Phoenix F, Kietsiriroje N, Ponnambalam S, Duval C, Ariëns RAS, Tiede C, Tomlinson DC, Ajjan R.
Pechlivani N, et al. Among authors: duval c.
Blood Adv. 2024 Nov 6:bloodadvances.2024014235. doi: 10.1182/bloodadvances.2024014235. Online ahead of print.
Blood Adv. 2024.
PMID: 39504559
Free article.